Brawanski, K.R.; Sprung, S.; Freyschlag, C.F.; Hoeftberger, R.; Ströbel, T.; Haybaeck, J.; Thomé, C.; Manzl, C.; Birkl-Toeglhofer, A.M.
Influence of MMR, MGMT Promotor Methylation and Protein Expression on Overall and Progression-Free Survival in Primary Glioblastoma Patients Treated with Temozolomide. Int. J. Mol. Sci. 2023, 24, 6184.
https://doi.org/10.3390/ijms24076184
AMA Style
Brawanski KR, Sprung S, Freyschlag CF, Hoeftberger R, Ströbel T, Haybaeck J, Thomé C, Manzl C, Birkl-Toeglhofer AM.
Influence of MMR, MGMT Promotor Methylation and Protein Expression on Overall and Progression-Free Survival in Primary Glioblastoma Patients Treated with Temozolomide. International Journal of Molecular Sciences. 2023; 24(7):6184.
https://doi.org/10.3390/ijms24076184
Chicago/Turabian Style
Brawanski, Konstantin R., Susanne Sprung, Christian F. Freyschlag, Romana Hoeftberger, Thomas Ströbel, Johannes Haybaeck, Claudius Thomé, Claudia Manzl, and Anna M. Birkl-Toeglhofer.
2023. "Influence of MMR, MGMT Promotor Methylation and Protein Expression on Overall and Progression-Free Survival in Primary Glioblastoma Patients Treated with Temozolomide" International Journal of Molecular Sciences 24, no. 7: 6184.
https://doi.org/10.3390/ijms24076184
APA Style
Brawanski, K. R., Sprung, S., Freyschlag, C. F., Hoeftberger, R., Ströbel, T., Haybaeck, J., Thomé, C., Manzl, C., & Birkl-Toeglhofer, A. M.
(2023). Influence of MMR, MGMT Promotor Methylation and Protein Expression on Overall and Progression-Free Survival in Primary Glioblastoma Patients Treated with Temozolomide. International Journal of Molecular Sciences, 24(7), 6184.
https://doi.org/10.3390/ijms24076184
